• News
  • North America

Science Corporation Raises US$400 Million Series D

Brain tech startup valued at US$3.5 billion after Series D funding.

11/17/2026
•Ghita Khalfaoui
Back to News

Science Corporation raised a US$400 million Series D round. The medical technology startup builds tools to understand and interact with the brain. Investors valued the company at US$3.5 billion, a person familiar with the deal told TechCrunch.


Backers and plans

The round included Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech. The company announced the financing in a blog post. It plans to use the capital to bring its device to the United States.

Company context

Science Corporation was founded in 2021 by Max Hodak. Hodak previously served as president of Neuralink. The startup focuses on technologies for understanding and interacting with the brain.

The PRIMA device

The company's first product is PRIMA, a wearable and implantable chip. It helps people with age-related macular degeneration recover some vision. The device is approved in Europe, available in Germany, and now in trials for Stargardt's disease.


Science Corporation aims to bring PRIMA to the United States through the FDA's Humanitarian Device Exemption. It has shown the FDA that advanced macular degeneration in both eyes is uncommon enough for that route. The company is also designing initial human trials of a bio-hybrid brain sensor with Yale neurosurgery professor Murat Günel.

Read more: techcrunch.com